Royalty Pharma RPRX
NASDAQ RPRX
$57.16 -0.47 (-0.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Royalty Pharma (RPRX) Cash & Equivalents (2019 - 2026)

Updated

Royalty Pharma (RPRX) reported Cash & Equivalents of $811.99 million for Q2 2026, up 28.5% from $631.91 million a year earlier and up 38.5% from the prior quarter.

Analysis

Royalty Pharma (RPRX) Cash & Equivalents (2019 - 2026) Analysis & Trends

At the end of FY2025, Royalty Pharma posted Cash & Equivalents of $618.7 million, down 33.4% from FY2024.

  • Cash & Equivalents has a five-year compound annual growth rate of -9.3% (FY2020 to FY2025).
  • By year, Cash & Equivalents came in at $929.03 million in FY2024 (+94.8%), $477.01 million in FY2023 (-72.1%), $1.71 billion in FY2022 (+11.0%) and $1.54 billion in FY2021 (+52.8%).
  • Five-year quarterly Cash & Equivalents spans a low of $477.01 million in Q4 2023 and a high of $2.17 billion in Q2 2023.
  • Year over year, Cash & Equivalents gained in four of the last eight quarters, with growth averaging 1.1%.
  • The high point for year-over-year Cash & Equivalents in five years was Q1 2022 (growth of 152.7%); the low point was Q4 2023 (a decline of 72.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $586.4 million (Q1 2026), $618.7 million (Q4 2025) and $938.94 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Rocket Companies 44.95 Bn 30.63 Bn - 3.10 Bn
2 Orix 41.97 Bn 42.47 Bn - 6.08 Bn
3 Royalty Pharma 33.14 Bn 33.05 Bn - 811.99 Mn
4 Federal National Mortgage Association Fannie Mae 24.99 Bn 24.99 Bn - -
5 Affirm Holdings 23.75 Bn 17.44 Bn - 1.63 Bn
6 Synchrony Financial 23.25 Bn -44.72 Bn - 16.19 Bn
7 Royal Gold 19.67 Bn 18.90 Bn 390.45 Mn 182.47 Mn
8 Annaly Capital Management 14.04 Bn 5.13 Bn - 2.91 Bn
9 Ares Capital 13.76 Bn 11.19 Bn - 383.00 Mn
10 Federal Home Loan Mortgage 12.58 Bn -6.16 Bn - 4.32 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 811.99 Mn
Mar 31, 2026 586.40 Mn
Dec 31, 2025 618.70 Mn
Sep 30, 2025 938.94 Mn
Jun 30, 2025 631.91 Mn
Mar 31, 2025 1.09 Bn
Dec 31, 2024 929.03 Mn
Sep 30, 2024 950.05 Mn
Jun 30, 2024 1.76 Bn
Mar 31, 2024 843.00 Mn
Dec 31, 2023 477.01 Mn
Sep 30, 2023 936.45 Mn
Jun 30, 2023 2.17 Bn
Mar 31, 2023 1.98 Bn
Dec 31, 2022 1.71 Bn
Sep 30, 2022 991.63 Mn
Jun 30, 2022 2.11 Bn
Mar 31, 2022 1.79 Bn
Dec 31, 2021 1.54 Bn
Sep 30, 2021 1.80 Bn
API Access

Royalty Pharma Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RPRX&period=max&api_key=YOUR_API_KEY